Mealey's (July 15, 2019, 2:40 PM EDT) -- WASHINGTON, D.C. — Appeals by myriad drug makers of a Delaware federal judge’s rejection of their challenge to the validity of several patents directed to Suboxone Film were largely unsuccessful July 12, when a divided Federal Circuit U.S. Court of Appeals agreed with the district court on nearly all issues presented in the case (Indivior Inc., et al. v. Dr. Reddy’s Laboratories SA, et al., Nos. 2017-2587, 2018-1010, -1058, -1062, -1114, -1115, -1176, -1177; Indivior Inc., et al. v. Alvogen Pine Brook LLC, Nos. 2018-1949, -2045, Fed. Cir., 2019 U.S. App. LEXIS 20680)....